Celldex Therapeutics Income Statement (2010-2025) | CLDX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2010	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	3.71M	2.41M	37.72M	2.52M	1.95M	2.36M	2.43M	2.43M	2.01M	3.11M	3.65M	2.41M	0.10M	0.98M	0.62M	0.42M	0.59M	1.10M	1.48M	0.49M	2.18M	1.03M	1.79M	1.30M	1.39M	2.22M	1.87M	1.53M	3.83M	3.92M	3.46M	4.07M	2.76M	0.94M	1.76M	1.43M	0.71M	0.55M	0.89M	1.80M	0.24M	0.67M	3.79M	0.69M	3.48M	0.15M	0.33M	0.17M	0.16M	0.41M	1.61M	0.97M	0.27M	1.52M	4.13M	0.16M	2.50M	3.19M	1.18M	0.69M	0.73M
Gross Profit	1.39M	1.19M	30.92M	0.01M	0.01M	0.04M	0.07M	0.09M	0.14M	0.11M	0.10M	0.08M																																												-1.15M	0.88M	2.12M		-1.47M	-0.81M
Operating items
Amortization - Intangibles	1.52M	0.48M	0.48M	0.48M	0.48M	0.66M	0.29M	0.29M	0.29M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.24M	0.22M	0.22M	0.22M	0.22M	0.22M
Research & Development	6.44M	7.21M	6.74M	6.85M	7.17M	8.59M	9.82M	10.77M	11.11M	11.77M	13.75M	14.09M	15.09M	20.42M	17.80M	27.07M	24.10M	26.18M	27.03M	25.12M	26.49M	24.66M	23.90M	27.45M	25.71M	25.01M	24.56M	25.79M	25.00M	21.91M	23.46M	21.88M	21.45M	11.92M	11.21M	11.15M	10.08M	11.10M	10.34M	11.70M	9.71M	10.71M	10.43M	12.72M	12.36M	13.56M	14.68M	17.06M	20.73M	21.57M	22.90M	26.80M	26.25M	34.53M	30.43M	31.66M	39.69M	45.26M	46.94M	52.61M	54.20M	62.93M
Wages, Salaries and Other																																																								11.44M	11.88M	13.86M		13.60M	14.13M	14.46M
Selling, General & Administrative	2.83M	2.42M	2.53M	2.34M	2.24M	2.27M	2.34M	2.32M	2.22M	2.83M	2.64M	3.14M	3.41M	3.58M	4.68M	4.58M	4.79M	5.00M	6.25M	6.09M	8.18M	8.49M	11.08M	9.31M	7.79M	6.95M	11.93M	7.23M	6.53M	5.35M	5.89M	5.59M	5.62M	3.72M	4.33M	4.90M	3.91M	3.40M	3.22M	3.67M	3.53M	3.64M	3.62M	4.12M	4.31M	5.82M	6.24M	6.91M	7.15M	6.53M	6.60M	6.64M	7.22M	8.22M	8.83M	9.10M	9.13M	10.05M	10.26M	10.82M	10.39M	10.69M
Other Operating Expenses	3.85M	0.05M	7.33M	2.98M	0.05M	2.97M	2.65M	2.63M	2.16M	3.26M	3.81M	2.59M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.24M	3.62M	1.22M	8.62M	-0.38M	13.60M	7.43M	6.93M	1.65M	-1.52M	1.02M	2.11M	-0.32M	-0.23M	5.13M	-0.70M	-0.02M	-0.50M	-0.30M	1.90M	0.20M	0.54M	-15.00M						-12.50M
Operating Expenses	13.12M	11.29M	16.61M	12.17M	11.83M	13.84M	14.82M	15.72M	15.50M	17.86M	20.20M	19.82M	18.75M	24.25M	22.73M	31.91M	29.14M	31.44M	33.53M	31.47M	34.93M	33.40M	35.23M	37.01M	33.76M	32.21M	36.73M	36.65M	32.76M	35.88M	28.98M	123.75M	19.64M	8.71M	13.89M	19.37M	12.97M	12.39M	13.88M	15.60M	11.60M	15.01M	28.57M	17.32M	16.92M	20.98M	20.67M	23.43M	36.56M	28.10M	29.50M	33.44M	33.47M	42.76M	51.76M	40.76M	48.81M	55.32M	57.20M	63.43M	64.59M	73.62M
Operating Income	-9.41M	-8.88M	21.12M	-9.66M	-9.88M	-11.48M	-12.38M	-13.29M	-13.49M	-14.75M	-16.55M	-17.40M	-18.66M	-23.27M	-22.11M	-31.49M	-28.55M	-30.34M	-32.05M	-30.98M	-32.75M	-32.37M	-33.44M	-35.70M	-32.37M	-29.99M	-34.85M	-35.11M	-28.93M	-31.96M	-25.53M	-119.68M	-16.87M	-7.76M	-12.12M	-17.94M	-12.26M	-11.84M	-12.99M	-12.87M	-11.37M	-14.34M	-24.78M	-16.64M	-13.44M	-20.82M	-20.34M	-23.26M	-36.40M	-27.70M	-27.89M	-32.47M	-33.20M	-41.24M	-47.63M	-40.61M	-46.32M	-52.13M	-56.03M	-62.74M	-63.86M	-73.62M
EBIT	-9.41M	-8.88M	21.12M	-9.66M	-9.88M	-11.48M	-12.38M	-13.29M	-13.49M	-14.75M	-16.55M	-17.40M	-18.66M	-23.27M	-22.11M	-31.49M	-28.55M	-30.34M	-32.05M	-30.98M	-32.75M	-32.37M	-33.44M	-35.70M	-32.37M	-29.99M	-34.85M	-35.11M	-28.93M	-31.96M	-25.53M	-119.68M	-16.87M	-7.76M	-12.12M	-17.94M	-12.26M	-11.84M	-12.99M	-12.87M	-11.37M	-14.34M	-24.78M	-16.64M	-13.44M	-20.82M	-20.34M	-23.26M	-36.40M	-27.70M	-27.89M	-32.47M	-33.20M	-41.24M	-47.63M	-40.61M	-46.32M	-52.13M	-56.03M	-62.74M	-63.86M	-73.62M
Non-operating items
Interest & Investment Income								0.20M	0.13M	0.10M	0.09M	0.38M	0.16M	0.14M	0.14M	1.59M	0.28M	2.26M	0.23M	0.81M	0.39M	0.39M	0.75M	1.03M	0.41M	0.40M	2.54M	0.85M	0.36M	0.40M	2.60M	0.78M	0.47M	0.52M	2.72M	0.70M	0.48M	0.43M	2.54M	0.24M	0.11M	0.12M	1.94M	0.10M	0.07M	0.14M	0.19M	0.21M	0.39M	0.91M	1.40M	3.11M	2.70M	2.98M	4.32M	7.80M	10.47M	10.01M	8.94M	8.94M	7.26M	6.57M
Non Operating Income	3.16M	0.12M	1.88M	0.08M	0.08M	0.14M	0.09M	0.20M	0.13M	0.10M
Net income details
EBT	-9.74M	-9.21M	20.78M	-10.14M	-10.31M	-11.92M	-12.82M	-13.52M	-13.77M	-15.03M	-16.81M	-17.33M	-19.02M	-23.14M	-22.06M	-29.90M	-28.27M	-28.08M	-31.82M	-30.17M	-32.36M	-31.98M	-32.68M	-34.67M	-31.95M	-29.60M	-32.31M	-34.26M	-28.57M	-31.56M	-22.92M	-118.90M	-16.41M	-7.24M	-9.40M	-17.24M	-11.78M	-11.41M	-10.45M	-12.62M	-12.62M	-14.22M	-22.84M	-16.54M	-13.37M	-20.68M	-20.15M	-23.05M	-36.00M	-26.78M	-26.49M	-29.36M	-30.50M	-38.26M	-43.31M	-32.81M	-35.84M	-42.12M	-47.09M	-53.80M	-56.60M	-67.04M
Tax Provisions																														-5.20M	-19.08M	-0.77M											-0.94M			-0.23M
Profit After Tax	-6.58M	-9.21M	20.78M	-10.14M	-10.06M	-11.92M	-12.82M	-13.52M	-13.77M	-15.03M	-16.81M	-17.33M	-19.02M	-23.14M	-22.06M	-29.90M	-28.27M	-28.08M	-31.82M	-30.17M	-32.36M	-31.98M	-32.68M	-34.67M	-31.95M	-29.60M	-32.31M	-34.26M	-28.57M	-26.36M	-3.84M	-118.13M	-16.41M	-7.24M	-9.40M	-17.24M	-17.24M	-11.41M	-10.45M	-12.62M	-12.62M	-14.22M	-21.90M	-16.54M	-13.37M	-20.45M	-20.15M	-23.05M	-36.00M	-26.78M	-26.49M	-29.36M	-30.50M	-38.26M	-43.31M	-32.81M	-32.81M	-42.12M	-47.09M	-53.80M	-53.80M	-67.04M
Income from Continuing Operations	-9.74M	-9.21M	20.78M	-10.14M	-10.31M	-11.92M	-12.82M	-13.52M	-13.77M	-15.03M	-16.81M	-17.33M	-19.02M	-23.14M	-22.06M	-29.90M	-28.27M	-28.08M	-31.82M	-30.17M	-32.36M	-31.98M	-32.68M	-34.67M	-31.95M	-29.60M	-32.31M	-34.26M	-28.57M	-26.36M	-3.84M	-118.13M	-16.41M	-7.24M	-9.40M	-17.24M	-11.78M	-11.41M	-10.45M	-12.62M	-12.62M	-14.22M	-21.90M	-16.54M	-13.37M	-20.45M	-20.15M	-23.05M	-36.00M	-26.78M	-26.49M	-29.36M	-30.50M	-38.26M	-43.31M	-32.81M	-35.84M	-42.12M	-47.09M	-53.80M	-56.60M	-67.04M
Consolidated Net Income	-9.74M	-9.21M	20.78M	-10.14M	-10.31M	-11.92M	-12.82M	-13.52M	-13.77M	-15.03M	-16.81M	-17.33M	-19.02M	-23.14M	-22.06M	-29.90M	-28.27M	-28.08M	-31.82M	-30.17M	-32.36M	-31.98M	-32.68M	-34.67M	-31.95M	-29.60M	-32.31M	-34.26M	-28.57M	-26.36M	-3.84M	-118.13M	-16.41M	-7.24M	-9.40M	-17.24M	-11.78M	-11.41M	-10.45M	-12.62M	-12.62M	-14.22M	-21.90M	-16.54M	-13.37M	-20.45M	-20.15M	-23.05M	-36.00M	-26.78M	-26.49M	-29.36M	-30.50M	-38.26M	-43.31M	-32.81M	-35.84M	-42.12M	-47.09M	-53.80M	-56.60M	-67.04M
Income towards Parent Company	-9.74M	-9.21M	20.78M	-10.14M	-10.31M	-11.92M	-12.82M	-13.52M	-13.77M	-15.03M	-16.81M	-17.33M	-19.02M	-23.14M	-22.06M	-29.90M	-28.27M	-28.08M	-31.82M	-30.17M	-32.36M	-31.98M	-32.68M	-34.67M	-31.95M	-29.60M	-32.31M	-34.26M	-28.57M	-26.36M	-3.84M	-118.13M	-16.41M	-7.24M	-9.40M	-17.24M	-11.78M	-11.41M	-10.45M	-12.62M	-12.62M	-14.22M	-21.90M	-16.54M	-13.37M	-20.45M	-20.15M	-23.05M	-36.00M	-26.78M	-26.49M	-29.36M	-30.50M	-38.26M	-43.31M	-32.81M	-35.84M	-42.12M	-47.09M	-53.80M	-56.60M	-67.04M
Net Income towards Common Stockholders	-9.74M	-9.09M	22.66M	-10.06M	-10.24M	-11.77M	-12.73M	-13.52M	-13.77M	-15.03M	-16.81M	-17.33M	-19.02M	-23.14M	-22.06M	-29.90M	-28.27M	-28.08M	-31.82M	-30.17M	-32.36M	-31.98M	-32.68M	-34.67M	-31.95M	-29.60M	-32.31M	-34.26M	-28.57M	-26.36M	-3.84M	-118.13M	-16.41M	-7.24M	-9.40M	-17.24M	-11.78M	-11.41M	-10.45M	-12.62M	-11.03M	-14.22M	-21.90M	-16.54M	-13.37M	-20.45M	-20.15M	-23.05M	-36.00M	-26.78M	-26.49M	-29.36M	-30.50M	-38.26M	-43.31M	-32.81M	-35.84M	-42.12M	-47.10M	-53.80M	-56.60M	-67.04M
Additional items
EPS (Basic)	-0.21	-0.28	0.71	-0.31	-0.27	-0.27	-0.29	-0.27	-0.23	-0.25	-0.27	-0.23	-0.24	-0.29	-0.27	-0.33	-0.32	-0.31	-0.36	-0.33	-0.33	-0.32	-0.33	-0.35	-0.32	-0.29	-0.30	-4.19	-3.42	-3.05	-0.42	-12.61	-1.67	-0.66	-0.81	-1.40	-0.84	-0.75	-0.64	-0.73	-0.50	-0.36	-0.55	-0.42	-0.34	-0.45	-0.43	-0.49	-0.77	-0.57	-0.57	-0.62	-0.65	-0.81	-0.84	-0.56	-0.54	-0.64	-0.71	-0.81	-0.85	-1.01
EPS (Weighted Average and Diluted)	-0.31	-0.28	0.71	-0.31	-0.27	-0.27	-0.32	-0.27																															-720.14				-738.87	-0.42	-0.34	-0.45	-0.43	-0.49	-0.77	-0.57	-0.57	-0.62	-0.65	-0.81	-0.84	-0.56	-0.54	-0.64	-0.71	-0.81	-0.85	-1.01
Shares Outstanding (Weighted Average)	2.12M	2.13M	2.14M	2.17M	2.17M	2.94M	2.94M	3.81M	3.92M	3.95M	5.37M	5.37M	5.39M	5.40M	5.95M	5.95M	5.96M	5.96M	5.97M	5.97M	6.57M	6.57M	6.58M	6.58M	6.58M	6.70M	6.75M	8.21M	8.34M	8.56M	9.07M	9.40M	9.56M	10.83M	11.50M	12.44M	15.02M	15.02M	16.13M	17.57M	39.13M	39.13M	39.57M	39.61M	39.61M	46.48M	46.74M	46.74M	46.75M	46.77M	47.10M	47.21M	47.25M	47.26M	47.26M	55.90M	65.91M	66.29M	66.34M	66.38M	66.39M	66.41M
Shares Outstanding (Diluted Average)	31.82M	31.92M	31.87M	32.05M	37.46M	44.14M	39.50M	50.15M																															0.01M				0.03M	39.61M	39.62M	45.45M	0.04M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.06M	0.07M	0.07M	0.06M	0.07M	0.07M	0.07M
EBITDA	-9.41M	-8.88M	21.12M	-9.66M	-9.88M	-11.48M	-12.38M	-13.29M	-13.49M	-14.75M	-16.55M	-17.40M	-18.66M	-23.27M	-22.11M	-31.49M	-28.55M	-30.34M	-32.05M	-30.98M	-32.75M	-32.37M	-33.44M	-34.29M	-31.92M	-29.71M	-32.38M	-34.24M	-28.55M	-26.35M	-3.87M	-118.14M	-16.38M	-7.25M	-9.40M	-17.22M	-11.74M	-11.42M	-10.46M	-12.65M	-11.03M	-14.21M	-21.92M	-16.54M	-13.37M	-20.50M	-20.80M	-24.83M	-36.53M	-26.48M	-25.11M	-28.50M	-30.55M	-38.20M	-42.13M	-33.87M	-36.31M	-38.61M	-49.07M	-53.54M	-56.83M	-66.62M
Interest Expenses	0.34M	0.33M	0.34M	0.48M	0.43M	0.44M	0.44M	0.43M	0.41M	0.38M	0.35M	0.31M	0.52M	0.01M	0.09M
Tax Rate																														16.47	83.24	0.64											4.11			1.10

Research Tools

Celldex Therapeutics Income Statement (2010-2025) | CLDX

Create an account

Sign In

Reset Password

Get Pro for 60% off